World Asthma Day 2024 - Asthma Education Empowers
Published in General & Internal Medicine
Despite strides in therapeutic development for asthma management, its morbidity and mortality persistently rise, particularly burdening low- and middle-income countries. To address this pressing need for deeper insight into asthma pathogenesis and therapeutic targets, Respiratory Research presents two focused issues that showcase cutting-edge discoveries in the field. The findings presented in both collections, “Asthma: Towards a Cure” and “Human Precision Cut Lung Slices: an Ex Vivo Platform for Therapeutic Target Discovery and Drug Testing in Lung Disease” will provide exciting discoveries furthering education and speaking to the theme of this year’s World Asthma Day – Asthma Education Empowers.
The first themed collection, "Asthma: Towards a Cure," compiles manuscripts delving into innovative science aimed at addressing the unmet challenge of managing and ultimately curing asthma. Within this collection, authors unveil novel biomarkers predicting therapeutic responses to both emerging and established treatments. Encompassing fundamental, translational, and clinical studies, these manuscripts not only disseminate new approaches but also strive to influence clinical practice and policy.
The second issue, "Human Precision Cut Lung Slices: an Ex Vivo Platform for Therapeutic Target Discovery and Drug Testing in Lung Disease,” spotlights the utility of an experimental platform mirroring the complexities of the in vivo lung environment. While precision cut lung slices (PCLS) have been utilized in respiratory research since the late 1970s, recent innovations have propelled their acceptance and expanded their applications across various domains. From toxicology and drug discovery to lung cancer biology and respiratory pathogen exposure, PCLS derived from both animal models and human lungs have significantly enhanced our understanding of integrated cellular responses, elucidating fundamental mechanisms in lung biology and providing a platform for therapeutic discovery.
Given the global impact of asthma, Respiratory Research is committed to sharing breakthroughs in asthma research, thereby contributing to the advancement of global health initiatives and providing education to both the scientific community and the general public to empower everyone to combat this disease.
Cynthia Koziol-White and Reynold A. Panettieri, Jr.
Rutgers University, New Brunswick, New Jersey USA
Follow the Topic
-
Respiratory Research
This journal publishes high-quality clinical and basic research, review and commentary articles on all aspects of respiratory medicine and related diseases.
Related Collections
With Collections, you can get published faster and increase your visibility.
Genetics in the clinical practice of rare respiratory diseases
As we delve deeper into the genetics of rare respiratory diseases, we can better address genetic clinical challenges, paving the way for enhanced patient care and improved outcomes. Recent advances in genetic testing technologies have revolutionized the landscape of rare respiratory diseases. For instance, the identification of monogenic causes of disorders such as cystic fibrosis and alpha-1-antitrypsin deficiency has led to more accurate diagnoses and personalized treatment strategies. These breakthroughs highlight the critical need for ongoing research and collaboration within the scientific community. This Collection aims to explore the intersection of genetics and rare respiratory diseases, focusing on genetic diagnosis and the clinical challenges faced. It seeks to highlight recent advances, encourage innovative research, and foster collaboration among professionals to enhance patient care and treatment outcomes in this vital area of respiratory medicine. We invite researchers to contribute to this special Collection by submitting original research articles and reviews. Topics of interest include but are not limited to:
- Genetic Diagnosis in Rare Respiratory Diseases
- Monogenic Causes of Cystic Fibrosis
- Clinical Challenges in Genetic Testing
- Advances in Pulmonary Hypertension Research
- Interstitial Lung Disease Genetics
- Impact of Genetic Research on Patient Care
- Alpha-1-Antitrypsin Deficiency Insights
- Emerging Therapeutic Approaches in Genetics
This Collection supports and amplifies research related to SDG 3, Good health and well-being.
All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.
Publishing Model: Open Access
Deadline: Dec 15, 2026
Personalized and Translational medicine
Personalized and translational medicine are emerging medical approaches that have the potential to transform healthcare. It is essential to develop translational biomarkers, diagnostic tests that can predict early therapy response or identify patient subgroups for chronic pulmonary disorders.
This Collection will focus in particular to the areas of chronic lung disease (Asthma, COPD, ILD, IPF, bronchiectasis, others)
- Translational biomarkers
- Preclinical and Clinical imaging studies (MRI, CT, PET/SPECT, optical)
- New translational mouse model
- Diagnostic methods
- Machine learning applications for prognosis and patient stratification
This Collection supports and amplifies research related to SDG 3, Good Health and Well-Being .
We are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or contact the Editor-in-Chief.
Publishing Model: Open Access
Deadline: Jul 02, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in